Barclays’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.13M Buy
292,095
+104,633
+56% +$404K ﹤0.01% 2589
2025
Q1
$938K Buy
187,462
+29,934
+19% +$150K ﹤0.01% 2487
2024
Q4
$1.14M Buy
157,528
+1,787
+1% +$12.9K ﹤0.01% 2557
2024
Q3
$956K Buy
155,741
+75,064
+93% +$461K ﹤0.01% 2642
2024
Q2
$535K Sell
80,677
-19,678
-20% -$130K ﹤0.01% 2498
2024
Q1
$1.02M Buy
100,355
+27,932
+39% +$284K ﹤0.01% 2391
2023
Q4
$814K Sell
72,423
-107,986
-60% -$1.21M ﹤0.01% 2746
2023
Q3
$470K Buy
180,409
+69,014
+62% +$180K ﹤0.01% 2588
2023
Q2
$394K Sell
111,395
-115,466
-51% -$408K ﹤0.01% 2741
2023
Q1
$957K Sell
226,861
-134,380
-37% -$567K ﹤0.01% 2163
2022
Q4
$5.94M Buy
361,241
+173,277
+92% +$2.85M ﹤0.01% 1021
2022
Q3
$2.4M Sell
187,964
-877,583
-82% -$11.2M ﹤0.01% 1531
2022
Q2
$12.5M Sell
1,065,547
-89,734
-8% -$1.05M 0.01% 751
2022
Q1
$7.04M Buy
1,155,281
+60,221
+5% +$367K 0.01% 1011
2021
Q4
$10M Buy
1,095,060
+812,041
+287% +$7.44M ﹤0.01% 895
2021
Q3
$3.2M Buy
283,019
+215,047
+316% +$2.43M ﹤0.01% 1532
2021
Q2
$670K Buy
67,972
+35,127
+107% +$346K ﹤0.01% 2320
2021
Q1
$464K Buy
32,845
+4,545
+16% +$64.2K ﹤0.01% 2694
2020
Q4
$319K Buy
28,300
+100
+0.4% +$1.13K ﹤0.01% 2519
2020
Q3
$372K Sell
28,200
-91,515
-76% -$1.21M ﹤0.01% 2444
2020
Q2
$1.28M Buy
+119,715
New +$1.28M ﹤0.01% 1773
2018
Q2
Sell
-1
Closed 4170
2018
Q1
$0 Buy
+1
New ﹤0.01% 4182
2017
Q3
Sell
-109
Closed -$10K 3995
2017
Q2
$10K Buy
109
+94
+627% +$8.62K ﹤0.01% 3426
2017
Q1
$3K Buy
+15
New +$3K ﹤0.01% 3703
2016
Q4
Sell
-1
Closed -$1K 3803
2016
Q3
$1K Buy
+1
New +$1K ﹤0.01% 3707
2016
Q2
Sell
-5
Closed -$1K 3583
2016
Q1
$1K Buy
+5
New +$1K ﹤0.01% 3272
2014
Q3
Hold
0
4323
2014
Q2
Hold
0
4277
2014
Q1
Hold
0
4276
2013
Q4
Hold
0
4314
2013
Q3
Sell
-5
Closed -$2K 4125
2013
Q2
$2K Buy
+5
New +$2K ﹤0.01% 4191